Moderna (NASDAQ: $MRNA) posted its fourth-quarter results on Friday, February 14, 2025, beating revenue estimates. However, losses came in higher than expected, causing the stock […]
Tag: stocks
Applied Materials (NASDAQ: AMAT) Dips After Q1 Fiscal 2025 Results On Soft Outlook: Is It Still Worth Investing In?
Applied Materials (NASDAQ: $AMAT) is a leader in the manufacture of materials used in virtually all new chips and displays worldwide. On Thursday, February 13, […]
Tiziana Life Sciences (NASDAQ: TLSA) Shows Great Promise With Intranasal Foralumab For Alzheimer’s Treatment
Tiziana Life Sciences (NASDAQ: $TLSA) is a biotech firm pushing the boundaries in the discovery and development of novel molecules to treat human diseases. On […]
Cisco Systems (NASDAQ: CSCO) Releases Q2 Fiscal 2025 Results: Is Cisco A Buy Amid AI Push?
Cisco Systems (NASDAQ: $CSCO) released its Q2 fiscal 2025 results on Wednesday, February 12, 2025, after markets closed, to a positive market reaction. The giant […]
Gilead Sciences (NASDAQ: GILD) Releases Q4 Fiscal 2024 Earnings: Is The Biotech Giant Still A Great Investment In 2025?
Gilead Sciences (NASDAQ: $GILD) is a biotech giant that develops and sells drugs and invests in public health programs. On Tuesday, February 12, 2025, after […]
Coca-Cola (NYSE: KO) Releases Q4 Fiscal 2024 Results: Is This Dividend Aristocrat Still A Buy in 2025?
Coca-Cola (NYSE: KO) is a global beverage company known for its soft drinks, bottled water, coffee, and tea. Following the earnings and revenue beat in […]